DOCSLIB.ORG

P53 Regulates the Cardiac Transcriptome

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
P53 Regulates the Cardiac Transcriptome p53 regulates the cardiac transcriptome Tak W. Maka,1, Ludger Hauckb, Daniela Grotheb, and Filio Billiab,c,d,e,1 aCampbell Family Cancer Research Institute, Princess Margaret Hospital, Toronto, ON, Canada M5G 2M9; bToronto General Research Institute, Toronto, ON, Canada M5G 1L7; cDivision of Cardiology, University Health Network, Toronto, ON, Canada M5G 2C4; dHeart and Stroke Richard Lewar Centre of Excellence, University of Toronto, Toronto, ON, Canada M5S 1A8; and eInstitute of Medical Science, University of Toronto, Toronto, ON, Canada M5G 1A8 Contributed by Tak W. Mak, January 20, 2017 (sent for review October 10, 2016; reviewed by Kanaga Sabapathy and Karen H. Vousden) The tumor suppressor Trp53 (p53) inhibits cell growth after acute identifying the factors that effectively maintain cardiac tissue ho- stress by regulating gene transcription. The mammalian genome meostasis is of great scientific and clinical importance. contains hundreds of p53-binding sites. However, whether p53 Elevated p53 levels correlate with CM apoptosis and hypertro- participates in the regulation of cardiac tissue homeostasis under phy in end-stage human HF (15). The heart, as an obligate aerobic normal conditions is not known. To examine the physiologic role of organ, has the largest mitochondrial (mt) content to meet its high p53 in adult cardiomyocytes in vivo, Cre-loxP–mediated conditional energy demand (16). Reactive oxygen species (ROS), normal by- gene targeting in adult mice was used. Genome-wide transcriptome products of aerobic respiration, induce DNA damage (17), thereby analyses of conditional heart-specific p53 knockout mice were per- activating cellular defense systems against ROS through stabiliza- formed. Genome-wide annotation and pathway analyses of >5,000 tion of p53 (18). Therefore, we hypothesized that impairment of differentially expressed transcripts identified many p53-regulated p53 will have deleterious consequencesontheheart.Herewere- gene clusters. Correlative analyses identified >20 gene sets contain- port that p53 forms a critical hub in a comprehensive transcrip- ing more than 1,000 genes relevant to cardiac architecture and func- tional network. Our study suggests that p53 acts as a pleiotropic tion. These transcriptomic changes orchestrate cardiac architecture, regulator of cardiac structure and function. excitation-contraction coupling, mitochondrial biogenesis, and oxida- tive phosphorylation capacity. Interestingly, the gene expression sig- Results nature in p53-deficient hearts confers resistance to acute Cardiac-Specific Ablation of p53 Induces Age-Dependent Cardiac biomechanical stress. The data presented here demonstrate a role Hypertrophy and HF. We crossed transgenic mice expressing Cre for p53, a previously unrecognized master regulator of the cardiac recombinase flanked by mutated estrogen receptors (MerCreMer; transcriptome. The complex contributions of p53 define a biological mcm) with mice carrying loxP-flanked alleles of p53 to obtain fl/fl paradigm for the p53 regulator network in the heart under p53 ;mcm animals. The day of the last injection was arbitrarily physiological conditions. set to 0. Four consecutive daily i.p. Tamoxifen (Tam) injections induced genetic ablation of p53 with high recombination efficiency heart failure | tumor suppressor | cardiac hypertrophy | transcriptome | (Fig. 1 A–C). To determine the physiological consequence of p53 fl/fl cardiomyopathy ablation, cardiac morphology and function in p53 ;mcm mice were assessed in the presence and absence of Tam. fl/fl he tumor suppressor Trp53 (p53) is a transcription factor that Although p53 ;mcm mice were initially normal post-Tam, they MEDICAL SCIENCES Ttranslates growth and survival signals into specific gene ex- developed concentric hypertrophy by 6 mo. These mice showed pression patterns, regulating tumor-free survival of an organism significant increases in heart weight/body weight (HBW) ratios (1). In normal cells, p53 expression is kept at low levels by the E3 (Fig. 1D)(P < 0.001) and wall thickening (Fig. 1E). In contrast, fl/fl ubiquitin ligase Mdm2, which targets p53 for proteasomal degra- p53 ;mcm mice developed normally in the absence of Tam (Fig. 1 dation (2). In response to acute stress, Mdm2 is inactivated and D and E). The cross-sectional area of cardiomyocytes was 1.5-fold fl/fl increased p53 levels block cell division and induce apoptosis (3). greater in p53 ;mcm mice post-Tam (46 ± 3.4%; P < 0.001) Conversely, p53 can activate Mdm2 transcription, thereby forming compared with vehicle-injected controls (Fig. 1 F and G). The a negative feedback loop that curtails p53 activity (4). Cells with analysis of cardiac performance by echocardiography on older fl/fl mutated p53 proliferate aberrantly and generate outgrowths of p53 ;mcm mice post-Tam revealed significant decreases in frac- genetically unstable cells, leading to tumorigenesis as demonstrated tional shortening (31 ± 4.5%)incomparisonwithvehicle-injected by the early cancer predisposition of p53 knockout mice (p53KO) (5). Loss of Mdm2 in mice leads to death in em- Significance bryogenesis through p53-induced apoptosis, which is prevented by p53 codeletion (6). These findings provide genetic evidence The tumor suppressor Trp53 (p53) is a gene that regulates the that Mdm2 exerts a physiologically critical role in regulating p53 expression of many genes. However, the role of p53 in the heart in vivo. has not been well characterized. This work documents the im- Adult mammalian cardiomyocytes (CM) are differentiated portant role for p53 in the heart as a master regulator of the postmitotic cells that lack significant proliferative potential cardiac transcriptome. The contribution of p53 to the mainte- through their inability to reactivate the cell cycle (7). This is caused nance of cardiac tissue homeostasis is complex under by the lack of G1 cyclin/cyclin-dependent kinases (Cdk), crucial physiological conditions. positive cell-cycle modulators, and high levels of cell-cycle inhibi- tors (8), such as the retinoblastoma proteins pRb/p130 (9) and the Author contributions: L.H. and F.B. designed research; L.H., D.G., and F.B. performed re- Cdk inhibitors (Cdki) p21/p27 (10). The limited mitotic capacity of search; T.W.M. and D.G. contributed new reagents/analytic tools; T.W.M., D.G., and F.B. analyzed data; and T.W.M., L.H., and F.B. wrote the paper. mature CM (11) renders the adult mammalian heart functionally Reviewers: K.S., National Cancer Centre; and K.H.V., Cancer Research United Kingdom unable to repair itself after ischemic injury (12). Instead, surviving Beatson Institute. CM undergo hypertrophy to compensate for the ensuing hemo- The authors declare no conflict of interest. dynamic stress manifested as cell enlargement, myofibrillar disar- Freely available online through the PNAS open access option. ray, and re-expression of fetal genes (13). This process becomes 1To whom correspondence may be addressed. Email: [email protected] or tmak@ maladaptive with time, leading to the development of heart failure uhnres.utoronto.ca. (HF) with significant morbidity and mortality (14). The molecular This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. mechanisms underlying HF remain poorly understood. As such, 1073/pnas.1621436114/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1621436114 PNAS | February 28, 2017 | vol. 114 | no. 9 | 2331–2336 Downloaded by guest on September 29, 2021 fl/fl cardiac contractility (Pln, Ryc2, Serca2a) in older p53 ;mcm mice post-Tam (Fig. 1J). Finally, sarcomere organization profoundly influences cardiac function with abnormalities in this structure commonly observed in human HF. Key contractile proteins fl/fl (Tpm1, Tnnc1, Tnnt1, Ttn) were down-regulated in older p53 ; mcm mice post-Tam (Fig. 1J), demonstrating that p53 is important for proper expression of the contractile apparatus. Beyond these genes, we also found key regulators of fatty acid metabolism and mitochondrial respiration to be transcriptionally down-regulated in older p53KO, including Esrrβ/γ,Pparα/γ, Pgc-1a, Tfam, and Tfb1/2m (Fig. 1J). These data strongly suggest that p53 acts in concert with other transcriptional components that are necessary for the regulation of physiological hypertrophy. p53-Deficient Hearts Are Resistant to Pressure Overload. We then examined the responses of p53 loss to mechanical stress in younger fl/fl mice by subjecting 10-wk-old Tam-treated p53 ;mcm mice to transaortic banding (TAB). After 3 wk of TAB, HBW in vehicle- fl/fl injected p53 ;mcm mice increased by 2.3-fold, compared with fl/fl Tam-treated sham p53 ;mcm animals (P < 0.001) (Fig. 2A). Vehicle-treated hearts subjected to TAB exhibited significantly greater dilatation and increases in left ventricular wall thickness fl/fl than Tam-injected p53 ;mcm mice (Fig. 2B). To confirm that higher HBW in control hearts after TAB represents cardiomyocyte hypertrophy, we determined that the width of cardiomyocytes from fl/fl hearts of vehicle-treated mice was 2.1-fold greater than in p53 ; mcm mice injected with Tam post-TAB (P < 0.001) (Fig. 2 C and D). This was accompanied with significantly higher levels of ANP, BNP, and β-MHC compared with p53-deficient hearts (Fig. 2E). Importantly, TAB treatment reduced fractional shortening in ve- fl/fl fl/fl hicle-injected p53 ;mcm mice, as compared with p53 ;mcm animals in the presence of Tam (P < 0.001) (Fig. 2F). fl/fl Fig. 1. Heart-specific ablation of p53 triggers age-dependent concentric hy- Next, we investigated the insensitivity of p53 ;mcm mice to pertrophy with cardiac dysfunction. (A)ImmunoblotanalysisofLVextracts TAB by immunoblotting of left ventricular lysates (Fig. 2 G–I). (60 μg total protein/lane) of p53fl/fl;mcm mice at various time points after Tam Mef2a, Pln, and Serca2 were markedly down-regulated in vehicle- using anti-p53 antibodies. Animals were 13 wk old. For normalization, West- treated p53KO, but not in Tam-treated p53KO (Fig. 2G). ern blots were probed with anti-nucleophosmin (Npm1). Immunoblots were repeated once with similar results. (B) PCR of DNA isolated from LV and liver samples of wild-type, vehicle-injected control p53fl/fl;mcm mice 7 d post-Tam.
Load more

Recommended publications
  • Mutant P53 Protects Cells from 12-O-Tetradecanoylphorbol-13- Acetate–Induced Death by Attenuatingactivating Transcription Factor 3 Induction
    Research Article Mutant p53 Protects Cells from 12-O-Tetradecanoylphorbol-13- Acetate–Induced Death by AttenuatingActivating Transcription Factor 3 Induction Yosef Buganim,1 Eyal Kalo,1 Ran Brosh,1 Hila Besserglick,1 Ido Nachmany,3 Yoach Rais,2 Perry Stambolsky,1 Xiaohu Tang,1 Michael Milyavsky,1 Igor Shats,1 Marina Kalis,1 Naomi Goldfinger,1 and Varda Rotter1 1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel; 2Department of Life Science, Bar-Ilan University, Ramat Gan, Israel; and 3Department of General Surgery B, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel Abstract mutated. Notably, the predominant mode of p53 inactivation is by Mutations in p53 are ubiquitous in human tumors. Some p53 point mutation rather than by deletion or truncation. These data mutations not only result in loss of wild-type (WT) activity but coupled with the observation that mutant p53 is generally highly also grant additional functions, termed ‘‘gain of function.’’ overexpressed in tumors have led to the hypothesis that mutant In this study, we explore how the status of p53 affects the p53 possesses gain-of-function activities. This hypothesis is immediate response gene activating transcription factor 3 supported by the results of in vivo and in vitro studies. For (ATF3) in the 12-O-tetradecanoylphorbol-13-acetate (TPA)- example, mice harboring mutant p53 display allele-specific tumor protein kinase C (PKC) pathway. We show that high doses of spectra, higher metastatic frequency, enhanced cell proliferation, TPA induce ATF3 in a WT p53-independent manner correlat- and higher transformation potential compared with their p53-null ingwith PKCs depletion and cell death.
    [Show full text]
  • Action on Muscle Metabolism and Insulin Sensitivity E Strong Enough for a Man, Made for a Woman
    Review The impact of ERa action on muscle metabolism and insulin sensitivity e Strong enough for a man, made for a woman Andrea L. Hevener*, Zhenqi Zhou, Timothy M. Moore, Brian G. Drew, Vicent Ribas ABSTRACT Background: The incidence of chronic disease is elevated in women after menopause. Natural variation in muscle expression of the estrogen receptor (ER)a is inversely associated with plasma insulin and adiposity. Moreover, reduced muscle ERa expression levels are observed in women and animals presenting clinical features of the metabolic syndrome (MetSyn). Considering that metabolic dysfunction impacts nearly a quarter of the U.S. adult population and elevates chronic disease risk including type 2 diabetes, heart disease, and certain cancers, treatment strategies to combat metabolic dysfunction and associated pathologies are desperately needed. Scope of the review: This review will provide evidence supporting a critical and protective role for skeletal muscle ERa in the regulation of metabolic homeostasis and insulin sensitivity, and propose novel ERa targets involved in the maintenance of metabolic health. Major conclusions: Studies identifying ERa-regulated pathways essential for disease prevention will lay the important foundation for the rational design of novel therapeutics to improve the metabolic health of women while limiting secondary complications that have plagued traditional hormone replacement interventions. Ó 2018 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Keywords Estrogen action; Estrogen receptors; Insulin sensitivity; Metabolic homeostasis 1. INTRODUCTION new-onset T2DM in postmenopausal women following HRT compared with placebo [7]. The mechanism by which HRT reduces T2D incidence For over two decades researchers have shown strong relationships in postmenopausal women is not yet known however molecular between estrogen action and metabolic health in women.
    [Show full text]
  • An Autoregulatory Loop Controls Peroxisome Proliferator-Activated Receptor Γ Coactivator 1Α Expression in Muscle
    Institutional Repository of the University of Basel University Library Schoenbeinstrasse 18-20 CH-4056 Basel, Switzerland http://edoc.unibas.ch/ Year: 2003 An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle Handschin, C. and Rhee, J. and Lin, J. and Tarr, P. T. and Spiegelman, B. M. Posted at edoc, University of Basel Official URL: http://edoc.unibas.ch/dok/A5258732 Originally published as: Handschin, C. and Rhee, J. and Lin, J. and Tarr, P. T. and Spiegelman, B. M.. (2003) An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle. Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, H. 12. S. 7111-7116. An Autoregulatory Loop Controls PGC-1 Expression in Muscle Christoph Handschin, James Rhee, Jiandie Lin, Paul T. Tarr, and Bruce M. Spiegelman* Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 Published in Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7111-6. PMID: 12764228. doi: 10.1073/pnas.1232352100 Copyright © National Academy of Sciences; Proceedings of the National Academy of Sciences USA Page 1 of 24 Classification: Biological Sciences, Cell Biology An Autoregulatory Loop Controls PGC-1 Expression in Muscle Christoph Handschin, James Rhee, Jiandie Lin, Paul T. Tarr, and Bruce M. Spiegelman* Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 * To whom
    [Show full text]
  • Myoferlin Regulation by NFAT in Muscle Injury, Regeneration and Repair
    Research Article 2413 Myoferlin regulation by NFAT in muscle injury, regeneration and repair Alexis R. Demonbreun1,2, Karen A. Lapidos2,3, Konstantina Heretis2, Samantha Levin2, Rodney Dale1, Peter Pytel4, Eric C. Svensson1,3 and Elizabeth M. McNally1,2,3,* 1Committee on Developmental Biology, 2Department of Medicine, 3Department of Molecular Genetics and Cell Biology, and 4Department of Pathology, The University of Chicago, 5841 South Maryland Avenue, MC 6088, Chicago, IL 60637, USA *Author for correspondence ([email protected]) Accepted 9 April 2010 Journal of Cell Science 123, 2413-2422 © 2010. Published by The Company of Biologists Ltd doi:10.1242/jcs.065375 Summary Ferlin proteins mediate membrane-fusion events in response to Ca2+. Myoferlin, a member of the ferlin family, is required for normal muscle development, during which it mediates myoblast fusion. We isolated both damaged and intact myofibers from a mouse model of muscular dystrophy using laser-capture microdissection and found that the levels of myoferlin mRNA and protein were increased in damaged myofibers. To better define the components of the muscle-injury response, we identified a discreet 1543-bp fragment of the myoferlin promoter, containing multiple NFAT-binding sites, and found that this was sufficient to drive high-level myoferlin expression in cells and in vivo. This promoter recapitulated normal myoferlin expression in that it was downregulated in healthy myofibers and was upregulated in response to myofiber damage. Transgenic mice expressing GFP under the control of the myoferlin promoter were generated and GFP expression in this model was used to track muscle damage in vivo after muscle injury and in muscle disease.
    [Show full text]
  • Interaction of Calcineurin with a Domain of Thetranscription Factor NFAT1 That Controls Nuclear Import
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 8907-8912, August 1996 Biochemistry Interaction of calcineurin with a domain of the transcription factor NFAT1 that controls nuclear import (protein phosphatase/nuclear localization sequence/immunosuppression/T cell activation/signal transduction) CHUN Luo*t#, KAREN T.-Y. SHAW*t§, ANURADHA RAGHAVANT, JOSE ARAMBURU*, FRANcisco GARCIA COZAR*, BRiAN A. PERRINOII, PATRICK G. HOGAN1, AND ANJANA RAO*,** *Division of Cellular and Molecular Biology, Dana-Farber Cancer Institute and Department of Pathology, and IDepartment of Neurobiology, Harvard Medical School, Boston, MA 02115; and IlThe Vollum Institute, Oregon Health Sciences University, Portland, OR 97201 Communicated by Stephen C. Harrison, Harvard University, Cambridge, MA, May 8, 1996 (received for review February 7, 1996) ABSTRACT The nuclear import of the nuclear factor of hallmarks of activation is dependent on calcineurin, since each activated T cells (NFAT)-family transcription factors is ini- is blocked by CsA or FK506 (30). Here we present evidence tiated by the protein phosphatase calcineurin. Here we iden- suggesting that the close control of NFAT1 activation by the tify a regulatory region of NFAT1, N terminal to the DNA- calcium/calcineurin pathway reflects a protein-protein inter- binding domain, that controls nuclear import of NFAT1. The action that targets calcineurin to NFAT1. regulatory region of NFAT1 binds directly to calcineurin, is a substrate for calcineurin in vitro, and shows regulated sub- cellular localization identical to that of full-length NFAT1. MATERIALS AND METHODS The corresponding region of NFATc likewise binds cal- cDNA Constructs. The cDNAs encoding murine NFAT1, cineurin, suggesting that the efficient activation ofNFAT1 and human NFAT1(1-415), murine NFAT1(399-927), and mu- NFATc by calcineurin reflects a specific targeting of the rine NFAT1(398-694) were subcloned into pEFTAG, a de- phosphatase to these proteins.
    [Show full text]
  • Global Mef2 Target Gene Analysis in Skeletal and Cardiac Muscle
    GLOBAL MEF2 TARGET GENE ANALYSIS IN SKELETAL AND CARDIAC MUSCLE STEPHANIE ELIZABETH WALES A DISSERTATION SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY GRADUATE PROGRAM IN BIOLOGY YORK UNIVERSITY TORONTO, ONTARIO FEBRUARY 2016 © Stephanie Wales 2016 ABSTRACT A loss of muscle mass or function occurs in many genetic and acquired pathologies such as heart disease, sarcopenia and cachexia which are predominantly found among the rapidly increasing elderly population. Developing effective treatments relies on understanding the genetic networks that control these disease pathways. Transcription factors occupy an essential position as regulators of gene expression. Myocyte enhancer factor 2 (MEF2) is an important transcription factor in striated muscle development in the embryo, skeletal muscle maintenance in the adult and cardiomyocyte survival and hypertrophy in the progression to heart failure. We sought to identify common MEF2 target genes in these two types of striated muscles using chromatin immunoprecipitation and next generation sequencing (ChIP-seq) and transcriptome profiling (RNA-seq). Using a cell culture model of skeletal muscle (C2C12) and primary cardiomyocytes we found 294 common MEF2A binding sites within both cell types. Individually MEF2A was recruited to approximately 2700 and 1600 DNA sequences in skeletal and cardiac muscle, respectively. Two genes were chosen for further study: DUSP6 and Hspb7. DUSP6, an ERK1/2 specific phosphatase, was negatively regulated by MEF2 in a p38MAPK dependent manner in striated muscle. Furthermore siRNA mediated gene silencing showed that MEF2D in particular was responsible for repressing DUSP6 during C2C12 myoblast differentiation. Using a p38 pharmacological inhibitor (SB 203580) we observed that MEF2D must be phosphorylated by p38 to repress DUSP6.
    [Show full text]
  • The Impact of Skeletal Muscle Erα on Mitochondrial Function And
    Copyedited by: oup MINI REVIEW The Impact of Skeletal Muscle ERα on Mitochondrial Function and Metabolic Health Downloaded from https://academic.oup.com/endo/article-abstract/161/2/bqz017/5735479 by University of Southern California user on 19 February 2020 Andrea L. Hevener1,2, Vicent Ribas1, Timothy M. Moore1, and Zhenqi Zhou1 1David Geffen School of Medicine, Department of Medicine, Division of Endocrinology, Diabetes, and Hypertension, University of California, Los Angeles, California 90095; and 2Iris Cantor-UCLA Women’s Health Research Center, University of California, Los Angeles, California 90095 ORCiD numbers: 0000-0003-1508-4377 (A. L. Hevener). The incidence of chronic disease is elevated in women after menopause. Increased expression of ESR1 (the gene that encodes the estrogen receptor alpha, ERα) in muscle is highly associated with metabolic health and insulin sensitivity. Moreover, reduced muscle expression levels of ESR1 are observed in women, men, and animals presenting clinical features of the metabolic syndrome (MetSyn). Considering that metabolic dysfunction elevates chronic disease risk, including type 2 diabetes, heart disease, and certain cancers, treatment strategies to combat metabolic dysfunction and associated pathologies are desperately needed. This review will provide published work supporting a critical and protective role for skeletal muscle ERα in the regulation of mitochondrial function, metabolic homeostasis, and insulin action. We will provide evidence that muscle-selective targeting of ERα may be effective for the preservation of mitochondrial and metabolic health. Collectively published findings support a compelling role for ERα in the control of muscle metabolism via its regulation of mitochondrial function and quality control. Studies identifying ERα-regulated pathways essential for disease prevention will lay the important foundation for the design of novel therapeutics to improve metabolic health of women while limiting secondary complications that have historically plagued traditional hormone replacement interventions.
    [Show full text]
  • The Repression of MEF2 Transcription Factors Exerted by Class Iia Hdacs
    81,9(56,7<2)8',1( BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB 3K'Course in Biomedical Sciences and Biotechnology ;;9,,&<&/( THE REPRESSION OF MEF2 TRANSCRIPTION FACTORS EXERTED BY CLASS IIA HDACS AND THEIR DEGRADATION STIMULATED BY CDK4 DETERMINE THE ACQUISITION OF HALLMARKS OF TRANSFORMATION IN FIBROBLASTS. 3K'6WXGHQW'L*LRUJLR(URV 7XWRUSURI&ODXGLR%UDQFROLQL (URV'L*LRUJLR To my family, Sara and those who believe in the research against cancer ABSTRACT 1 RIASSUNTO 2 INTRODUCTION 3 1. The HDACs world 3 2. Class IIa HDACs: similarities and differences between class IIa and class I HDACs 4 3. Class IIa HDACs: HDACs with orphan substrates or missed during evolution? 7 4. Pathways of regulation 10 a) regulation of class IIa HDACs transcription and modulation of the stability of the messengers (RNAi) 10 b) sub-cellular localization 11 5. Partners and biological functions 20 6. Class IIa HDACs as regulators of proliferation and cancer 28 7. MEF2 family of transcription factors 37 8. On the molecular basis of the MEF2-Class IIa HDACs axis: structure of MEF2/DNA, MEF2/Cabin1/DNA, MEF2/HDAC9/DNA and MEF2/DNA/p300 complexes. 38 9. Pathways of regulation 40 a) binding to repressors and co-activators 41 b) post-translational modifications 42 c) regulation of MEF2s transcription and modulation of the stability of the messengers (RNAi) 49 d) regulation of protein stability 51 10. Main functional roles 53 11. MEF2 as a regulator of differentiation programs 54 12. A lesson from the study of the knock-outs. 56 The role of MEF2s and of the MEF2-class IIa HDACs axis in myogenesis 57 The role of MEF2 TFs in cardiomyogenesis 59 The role of MEF2 TFs and of the MEF2-class IIa HDACs axis in endochondral bone ossification 59 The role of MEF2s and of the MEF2-class IIa HDACs axis in vasculogenesis and differentiation of vascular smooth muscle cells 60 The role of MEF2 TFs in neuronal development 60 The role of MEF2s in hematopoiesis and T cell development 61 The role of MEF2s in melanogenesis 62 The role of MEF2s in neural crest development 62 1.
    [Show full text]
  • Cytoplasmic-Nuclear Localization of NFAT Responsiveness By
    The Journal of Immunology Active Protein Kinase B Regulates TCR Responsiveness by Modulating Cytoplasmic-Nuclear Localization of NFAT and NF-␬B Proteins1 Amiya K. Patra, Shin-Young Na, and Ursula Bommhardt2 T cell activation leads to the induction of the transcription factors of the NFAT and NF-␬B families, important regulators of T cell activation and function. In this study we demonstrate that TCR/CD3-stimulated T cells from mice expressing a constitutively active form of protein kinase B (myr PKB␣) lack significant nuclear accumulation/shuttling of NFATc1 and NFATp as well as NF-␬〉p65 and RelB proteins. Notably, despite this deficit in nuclear NFAT and NF-␬B proteins, myr PKB T cells show lower activation threshold for proliferation, enhanced cell cycle progression and increased production of Th1 and Th2 cytokines similar to signals provided by CD28 costimulation. The enhanced T cell response correlates with increased expression of cyclins D3 and B1 and cytokine-induced Src homology 2 protein, and inactivation of the forkhead transcription factor FKHR. In addition, coimmunoprecipitation studies indicate a direct regulation of NFATc1 by active PKB. Together, our results demonstrate that the positive regulatory role of myr PKB on TCR responsiveness, subsequent cell division, and effector function is linked to a negative regulatory mechanism on the nuclear accumulation/shuttling of NFAT and NF-␬〉 proteins. The Journal of Immunology, 2004, 172: 4812–4820. D4 T cell activation, expansion, and differentiation re- by the immunosuppressants cyclosporin A (CsA)3 or FK506 pre- quire recognition of specific Ag presented by MHC class vents activation and nuclear entry of NFAT.
    [Show full text]
  • The Role of Hif-1Alpha in Epigenetic Regulation of Transcription
    From Department of Cell & Molecular Biology (CMB) Karolinska Institutet, Stockholm, Sweden THE ROLE OF HIF-1ALPHA IN EPIGENETIC REGULATION OF TRANSCRIPTION Nikola Vojnovic Stockholm 2018 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by E-Print AB 2018 © Nikola Vojnovic, 2018, ISBN 978-91-7831-274-0 The role of HIF-1alpha in epigenetic regulation of transcription THESIS FOR DOCTORAL DEGREE (Ph.D.) By Nikola Vojnovic Principal Supervisor: Opponent: Randall S Johnson Sven Påhlman Karolinska Institutet Lund Universitet Department of CMB Department of Translation cancer research Co-supervisor(s): Examination Board: Katarina Gradin Ann-Kristin Östlund Farrants Karolinska Institutet Stockholm University Department of CMB Department of Molecular Bioscience Wenner-Gren Susanne Schiliso Karolinska Institutet Department of MTC Martin Rottenberg Karolinska Institutet Department of MTC “The significant problems we have cannot be solved at the same level of thinking with which we created them”. - Albert Einstein ABSTRACT The oxygen level inside cells, determine the amount of HIF protein. By directly being involved in HIF protein turnover rates, through a mechanism, by which, oxygen is utilized as a co-factor, for the PHD enzymes, regulating HIF protein stability. This allows for rapid stabilization of the HIFs and subsequent gene activation during low oxygen tensions inside cells. I investigated the role of HIF specific epigenetic effects, in cancer cell line models, as well as primary mouse CD8+ T-lymphocytes. The data in Paper I illustrates how HIF has the ability to modulate chromatin through a HIF-1α dependent chromatin remodeling event, in hypoxia responsive gene promoters.
    [Show full text]
  • The Function of the MEF2 Family of Transcription Factors in Cardiac Development, Cardiogenomics, and Direct Reprogramming
    Journal of Cardiovascular Development and Disease Review The Function of the MEF2 Family of Transcription Factors in Cardiac Development, Cardiogenomics, and Direct Reprogramming Cody A. Desjardins and Francisco J. Naya * Department of Biology, Program in Cell and Molecular Biology, Boston University, 24 Cummington Mall Boston, Boston, MA 02215, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-617-353-2469; Fax: +1-617-353-6340 Academic Editors: Sean M. Wu and Neil C. Chi Received: 5 June 2016; Accepted: 8 August 2016; Published: 11 August 2016 Abstract: Proper formation of the mammalian heart requires precise spatiotemporal transcriptional regulation of gene programs in cardiomyocytes. Sophisticated regulatory networks have evolved to not only integrate the activities of distinct transcription factors to control tissue-specific gene programs but also, in many instances, to incorporate multiple members within these transcription factor families to ensure accuracy and specificity in the system. Unsurprisingly, perturbations in this elaborate transcriptional circuitry can lead to severe cardiac abnormalities. Myocyte enhancer factor–2 (MEF2) transcription factor belongs to the evolutionarily conserved cardiac gene regulatory network. Given its central role in muscle gene regulation and its evolutionary conservation, MEF2 is considered one of only a few core cardiac transcription factors. In addition to its firmly established role as a differentiation factor, MEF2 regulates wide variety of, sometimes antagonistic, cellular processes such as cell survival and death. Vertebrate genomes encode multiple MEF2 family members thereby expanding the transcriptional potential of this core transcription factor in the heart. This review highlights the requirement of the MEF2 family and their orthologs in cardiac development in diverse animal model systems.
    [Show full text]
  • Dephosphorylation of the Nuclear Factor of Activated T Cells (NFAT) Transcription Factor Is Regulated by an RNA-Protein Scaffold Complex
    Correction BIOCHEMISTRY Correction for “Dephosphorylation of the nuclear factor of ac- B. Sacks, and Anjana Rao, which appeared in issue 28, July 12, tivated T cells (NFAT) transcription factor is regulated by an 2011, of Proc Natl Acad Sci USA (108:11381–11386; first pub- RNA-protein scaffold complex,” by Sonia Sharma, Gregory M. lished June 27, 2011; 10.1073/pnas.1019711108). Findlay, Hozefa S. Bandukwala, Shalini Oberdoerffer, Beate The authors note that, due to a printer’s error, Fig. 1 appeared Baust, Zhigang Li, Valentina Schmidt, Patrick G. Hogan, David incorrectly. The corrected figure and its legend appear below. A C 670 kDa 158 kDa 670 KDa 158 KDa 52 54 56 58 60 62 64 66 68 V IB: NFAT1 Fraction: 5052 54 56 5860 62 64 66 68 70 72 74 76 250 IB: IQGAP1 IB: NFAT1 150 100 IB: IQGAP2 5052 54 56 5860 62 64 66 68 70 72 74 76 250 IB: CaM IB: IQGAP1 150 IB: CK1 ε 100 IB: CnA B 100 bp Fr. 54-60 Fr. 74-80 Fr. 87-93 Load H2O NFAT1: +-- High Low protein protein Fig. 1. NFAT1 coelutes with IQGAP and NRON in resting T cell lysates by size-exclusion chromatography. Hypotonic lysates from (A and B) HA-NFAT1 Jurkat T cells or (C) primary murine CD8+ T cells were fractionated on a Superdex 200 size-exclusion column. (A and C) Individual fractions were analyzed by SDS-PAGE and Western blotting for NFAT1, IQGAP1, IQGAP2, calmodulin (CaM), casein kinase epsilon (CK1ε) and calcineurin A (CnA). Column void volume (V)isin- dicated.
    [Show full text]